Karen Bernstein
CIK 1654055 · last filed 2026-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$44.4K
Companies
4
Total Filings
26
Lifetime Open-Market Net
$82.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OVID | Director | 20,000 | $2.22 | $44.4K | $82.5K | 16 | 2026-03-02 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Director | 8,750 | $0.06 | $499 | $0 | 5 | 2023-02-21 |
| Achaogen, Inc. (AKAO) Delisted | Director | — | — | — | $0 | 2 | 2018-06-07 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 3 | 2016-10-25 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-22 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | OVID | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | OVID | Grant (A) | — | $0 | EDGAR |
| 2020-10-15 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | OVID | Grant (A) | — | $0 | EDGAR |
| 2019-11-15 | OVID | Grant (A) | — | $0 | EDGAR |
| 2019-08-01 | OVID | Grant (A) | — | $0 | EDGAR |
| 2019-06-10 | OVID | Grant (A) | — | $0 | EDGAR |
| 2019-02-28 | OVID | Buy (P) | +10,000 | $20.2K | EDGAR |
| 2018-08-16 | OVID | Buy (P) | +10,000 | $62.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.